A sumatriptan iontophoretic transdermal system for the acute treatment of migraine.

Abstract

OBJECTIVE Gastrointestinal symptoms, such as nausea and vomiting, occur almost universally at one time or another in patients during a migraine attack. One third of patients who experience migraine-related nausea report that this symptom interferes with their ability to take oral medications. The sumatriptan iontophoretic transdermal system (NuPathe Inc… (More)
DOI: 10.1111/j.1526-4610.2012.02198.x

4 Figures and Tables

Topics

  • Presentations referencing similar topics